Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Bioconjugate Chemistry|August 24, 2011
Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compoundsRussell Clayton, Janee Hardman, Celia C LaBranche, et al.
ACS Applied Polymer Materials|March 8, 2021
An Efficient Microwave-Mediated Synthesis of Hexavalent Sialic Acid Sulfoglycodendrimers as Potential Anti-HIV AgentsCory Vierra, Daryl K Eggers, Celia C LaBranche, et al.
AIDS Research and Human Retroviruses|April 8, 2015
A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody ResponsesAmber Dunkel, Shixue Shen, Celia C LaBranche, et al.
The Journal of Biological Chemistry|February 7, 2002
Mutations that destabilize the gp41 core are determinants for stabilizing the simian immunodeficiency virus-CPmac envelope glycoprotein complexJie Liu, Shilong Wang, James A Hoxie, et al.
AIDS (London, England)|July 11, 2008
Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individualsDavid M Irlbeck, Heather Amrine-Madsen, Kathryn M Kitrinos, et al.
Scientific Reports|June 14, 2018
Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virusVinoth K Manoharan, Sunil K Khattar, Celia C LaBranche, et al.
Mbio|July 23, 2015
Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag ChallengesSunil K Khattar, Vinoth Manoharan, Bikash Bhattarai, et al.
Plos One|October 8, 2013
Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vectorSunil K Khattar, Sweety Samal, Celia C LaBranche, et al.
Journal of Virology|November 20, 2015
Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 ProteinsSunil K Khattar, Anthony L DeVico, Celia C LaBranche, et al.
Human Vaccines & Immunotherapeutics|February 20, 2015
Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virusSunil K Khattar, Senthilkumar Palaniyandi, Sweety Samal, et al.
Pageof 13